Search Results - Joanna Pikiel

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study

    microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study by Michał Kunc, Marta Popęda, Anna Szałkowska, Magdalena Niemira, Michał Bieńkowski, Rafał Pęksa, Aleksandra Łacko, Barbara S. Radecka, Marcin Braun, Joanna Pikiel, Maria Litwiniuk, Katarzyna Pogoda, Ewa Iżycka-Świeszewska, Adam Krętowski, Anna J. Żaczek, Wojciech Biernat, Elżbieta Senkus-Konefka

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    370 Time course of treatment-related adverse events (TRAEs) during dostarlimab therapy in the GARNET trial

    370 Time course of treatment-related adverse events (TRAEs) during dostarlimab therapy in the GARNET trial by Ana Oaknin, Maria-Pilar Barretina-Ginesta, Victor Moreno, Thierry André, Ruth Plummer, Florence Joly, Rowan Miller, Joanna Pikiel, Susana Banerjee, Jose Manuel Trigo Perez, Bhavana Pothuri, Andrea Jewell, Anna Tinker, Dominique Berton, Susan Ellard, Jennifer Veneris, Tao Duan

    Published 2021-11-01
    Article
    Save to List
    Saved in:
  3. 3
    Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

    Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma by Gabriella Liszkay, Catriona McNeil, Michele Maio, Vanna Chiarion-Sileni, Luc Thomas, Andrzej Mackiewicz, Michelle Del Vecchio, Ana Arance, Laurent Mortier, Lars Bastholt, Brigitte Dreno, Marta Nyakas, Michael Smylie, Christoph Hoeller, Virginia Ferraresi, Florent Grange, Joanna Pikiel, Fareeda Hosein, Burcin Simsek

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: